; and (V) for any underground injection operation that results in fluids returning to the surface, such as flowback after hydraulic fracturing or produced water recovered from an enhanced recovery project, a quarterly report of recovered fluids that includes the source, volume, and specific composition and disposition of all water, including water used as base fluid during the injection operation and produced water that is recovered from the well following injection and during the production phase. (ii) The State or the Administrator, as applicable, shall make the disclosure of baseline water testing results and chemical constituents referred to in clause (i) available to the public, including by posting the information on an appropriate internet website. (iii) Whenever the State or the Administrator, or a treating physician or nurse, determines that a medical emergency exists and the proprietary chemical formula of a chemical used in underground injection operations is necessary for medical treatment, the person conducting the underground injection operations shall, upon request, immediately disclose the proprietary chemical formulas or the specific chemical identity of a trade secret chemical to the State, the Administrator, or the treating physician or nurse, regardless of whether a written statement of need or a confidentiality agreement has been provided. The person conducting the underground injection operations may require a written statement of need and a confidentiality agreement as soon thereafter as circumstances permit. (B) Notwithstanding any other provision of law, none of the following information shall be protected as a trade secret: (i) The identities, including Chemical Abstracts Service identification numbers, of the chemical constituents of additives used in underground injection projects, including well stimulation treatment fluids and routine maintenance fluids. (ii) The concentrations of the additives in fluids used in underground injection projects. (iii) Any air or other pollution